Blockchain Registration Transaction Record

New Report Reveals 340B Program's Impact on Executive Compensation and Charity Care Provision

New report from ADAP Advocacy and CANN highlights the 340B Program's impact on executive compensation and charity care provision. The findings urge a reevaluation of the program's priorities to better serve patients.

This news matters because it sheds light on the financial implications of the 340B Drug Pricing Program for covered entities, indicating a significant increase in annual revenues and executive compensation. The findings raise concerns about the program's original intent and its impact on charity care provision, prompting a reevaluation of its priorities to better serve patients.